Xist localization and function: new insights from multiple levels by unknown
REVIEW Open Access
Xist localization and function: new insights
from multiple levels
Andrea Cerase1*, Greta Pintacuda2, Anna Tattermusch2 and Philip Avner1,3*
Abstract
In female mammals, one of the two X chromosomes in
each cell is transcriptionally silenced in order to achieve
dosage compensation between the genders in a
process called X chromosome inactivation. The master
regulator of this process is the long non-coding RNA
Xist. During X-inactivation, Xist accumulates in cis on
the future inactive X chromosome, triggering a cascade
of events that provoke the stable silencing of the entire
chromosome, with relatively few genes remaining
active. How Xist spreads, what are its binding sites, how
it recruits silencing factors and how it induces a specific
topological and nuclear organization of the chromatin
all remain largely unanswered questions. Recent studies
have improved our understanding of Xist localization
and the proteins with which it interacts, allowing a
reappraisal of ideas about Xist function. We discuss
recent advances in our knowledge of Xist-mediated
silencing, focusing on Xist spreading, the nuclear
organization of the inactive X chromosome, recruitment
of the polycomb complex and the role of the nuclear
matrix in the process of X chromosome inactivation.
Introduction
X chromosome inactivation (XCI) is the mechanism that
has evolved in eutherian mammals to ensure dosage com-
pensation between XX (female) and XY (male) individuals.
Dosage compensation depends on the efficient silencing
of genes on one of the two X chromosomes in each cell of
the female early in development. This process is crucially
dependent on a specific locus on the X — the X inactiva-
tion center (XIC) — which includes, among other genetic
elements, the Xist gene, which is necessary for the process
of XCI [1]. Xist encodes a 17-kb long non-coding RNA
(lncRNA) that, despite being capped, spliced and poly-
adenylated, is retained in the nucleus.
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In mouse, XCI occurs in two different fashions. During
early embryogenesis, the paternal X is preferentially
inactivated (imprinted XCI). At the blastula stage, in the
cells of the inner cell mass, this imprinted XCI is
reverted, and each chromosome in such cells has an
equal chance to be inactivated (random XCI). Initiation
of XCI is associated with the monoallelic upregulation of
Xist and its spreading and coating in cis of the presump-
tive inactive X (initiation phase of XCI). This triggers a
cascade of events, including the acquisition of repressive
chromatin modifications, exclusion of RNA polymerase
II (Pol II) and removal of active histone marks, histone
exchange and DNA methylation. These events act in
concert to ensure the stable repression of the entire
chromosome and the maintenance of the silent state
(maintenance phase of XCI) [2–5].
Although many studies have described various aspects
of the underlying XCI mechanism, we are far from hav-
ing a complete understanding of the process, especially
at the molecular level. For example, we currently still do
not have definitive answers to questions such as how
Xist triggers silencing, how it recruits chromatin remo-
delers or how the silent state is maintained.
Here, we review recent progress in the field, pointing
out the strengths, weaknesses and inconsistencies of
recent findings. In particular, we highlight recent evi-
dence indicating that chromosomal topology, nuclear
organization, and chromatin accessibility all have key
roles in the XCI process [6].
Xist spreading and nuclear organization of the inactive X
chromosome
Two recently published studies have shed light on Xist
spreading and localization [7, 8] (and are commented
upon elsewhere [9, 10]). Taking advantage of labeled
probes complementary to Xist, pulldowns of Xist-
associated chromatin at different stages of XCI were
obtained and analyzed by next-generation DNA se-
quencing [capture hybridization analysis of RNA
targets (CHART) and RNA antisense purification-
sequencing (RAP-Seq); Box 1]. The studies cover both
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Box 1 Studying X chromosome inactivation
Models of X inactivation
To study X chromosome inactivation (XCI) and its role in mammalian development, different model systems are used. Differentiating
female (XX) embryonic stem cells (ESCs) recapitulate quite closely the early stages of XCI described in the embryo. Female ESCs can be
differentiated by using the vitamin A derivative retinoic acid (RA) or by means of removal of leukemia inhibitory factor (LIF; an anti-
differentiation agent). Exposure to RA induces transcription of specific target genes triggering differentiation. Culturing cells in the absence of
LIF (LIF removal) leads to differentiation of cells and formation of embryoid bodies (EBs). EBs are three-dimensional multicellular aggregates
that can have a very non-homogeneous cellular composition. Transgenic ESCs (XX or XY) bearing an inducible Xist-transgene (Xist-Tg)
are another commonly used model in XCI research. These transgenes allow for the tightly controlled expression of Xist RNA. Induction
of Xist in this model system has been used for a model of XCI under undifferentiated condition. Mouse embryonic fibroblasts (MEFs)
are used as a model of the final step of XCI as they are fully differentiated cells in which XCI has already occurred.
Culturing of ESCs
ESCs are generally cultured in high-serum, LIF-containing growth media. Additionally, they are often grown on a layer of fibroblast feeder
cells that assist the maintenance of pluripotency. Alternatively, ESCs can be cultured in 2 inhibitory (2i) medium, which contains LIF and
two inhibitors, one blocking the mitogen-activated protein kinase signaling molecule Mek and the other inhibiting the glycogen synthase
kinase-3 (Gsk3) pathway.
Mapping the localization of ncRNAs
CHART is a technique — conceptually similar to chromatin immunoprecipitation (ChIP) — that is used to analyze RNA distribution over
a given genomic location or on a full genomic scale. In CHART, oligonucleotides complementary to the non-coding RNAs (ncRNAs) of
interest are used to specifically enrich for the target RNA-associated DNA (RNA is crosslinked to proteins that are crosslinked to DNA).
Through this, RNA associations to chromatin can be mapped to the genome by high-throughput sequencing. RNA antisense purification
(RAP) is a variant of CHART. It utilizes tagged RNA probes to capture in vivo targets of ncRNAs. Once the DNA targets are purified,
high-throughput sequencing is used to map these onto the genome.
Discovery of ncRNA–protein interactions
RNA antisense purification with mass spectrometry (RAP-MS) is a technique used to identify proteins directly interacting with ncRNAs
in vivo. It exploits in vivo UV crosslinking in order to covalently bind RNA-interacting proteins. Interacting proteins are then recovered by
immunoprecipitation (IP) of ncRNA complementary probes in denaturing conditions. This is followed by quantitative mass spectrometry.
Chromatin isolation by RNA purification-mass spectrometry (ChIRP-MS) is a method to identify, in vivo, direct and indirect interactions
between ncRNAs and proteins. This technique takes advantage of chemical crosslinking to purify ncRNA-neighbouring proteins by IP of
ncRNA-complementary probes under non-denaturing conditions. This is followed by mass spectrometry.
Studying chromosome conformations
3C/4C and Hi-C are high-throughput circular chromosome conformation capture methods used to analyze in vivo DNA–DNA interactions.
Typically, DNA and interacting proteins are crosslinked with formaldehyde. Through intramolecular ligation cloning, PCR amplification and
DNA sequencing, fragments of DNA that were in close three-dimensional proximity are identified. These techniques can be complemented
by a variety of super-resolution microscopy techniques such as three-dimensional structured illumination microscopy (3D-SIM) that enhances
biological imaging beyond the diffraction limit of wide-field microscopy. In 3D-SIM, the sample is illuminated with spatially structured
excitation light. Mathematical analysis of the diffraction patterns allows an increase of the resolution limit to ~100 nm. Super-resolution
microscopy allows enhanced resolution of the interchromatin, a series of channels between CTs, the perichromatin, a thin layer of
de-condensed chromatin around the chromosomal periphery and the chromatin compartment, where relatively more compressed
chromatin is present.
Mapping RNA–protein interactions
A variety of techniques are used to investigate RNA–protein interactions. Conventional RNA immunoprecipitations (RNA-IPs) are relatively
nonspecific pulldowns used to verify possible RNA–protein interactions. Crosslinking and immunoprecipitation (CLIP) is one of the most
recent techniques developed to unambiguously identify RNA–protein interactions by covalently linking proteins and RNA substrates by
UV crosslinking. After immunopurification of these complexes, high-throughput sequencing is used to identify the target RNAs.
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the initiation phase [recapitulated in differentiating fe-
male embryonic stem cells (ESCs) and male inducible-
Xist ESCs], and the maintenance phase of XCI (studied
in fully differentiated female fibroblasts; Box 1). Im-
portantly, the different experimental systems used
were complementary, compensating for the potential
limitations of each system. For instance, in the male in-
ducible-Xist cell lines used by Engreitz and colleagues
[7], Xist upregulation can be both more rapid and in-
tense than that occurring at the endogenous Xist locus.
It is also possible that early time-points in the indu-
cible systems correspond to relatively late time-points
in differentiating female ESC lines [11, 12]. Finally, Xist
upregulation in the inducible system is both well syn-
chronized and relatively homogeneous [11], whereas
ex vivo differentiation of ESC systems is often both
asynchronous and non-homogeneous [6].
The principle result from both papers is the observation
that Xist localization is initially restricted to a few discrete
genomic locations, before extending more broadly over the
entire chromosome. Xist coating starts within silent gene-
dense regions and then proceeds to spread to active genes
on the entire presumptive Xi. Both studies [7, 8] also con-
firmed that Xist accumulation at active genes requires the
presence of Xist A-repeats, a class of structurally conserved
repeats, previously identified as necessary for Xist-
mediated silencing [12].
The two studies concur to show that, once spread,
Xist is associated with gene-rich, open chromatin re-
gions (high-affinity sites), which are enriched for the
presence of short interspersed nuclear elements
(SINEs) and anti-correlated with the presence of long
interspersed nuclear elements (LINEs) and lamin
interaction sites [7, 8]. These observations are in keep-
ing with older cytological evidence suggesting a strong
association of Xist localization with G-light bands
(gene-rich regions), with gene-poor regions represent-
ing, predominantly, Xist low-affinity sites [13, 14]
(Fig. 1a).
Strikingly, both papers highlight a strong dependence
of Xist localization on the relative positioning of the
Xist locus (XIC). Engreitz and colleagues [7] elegantly
showed that moving the inducible Xist integration site
from its endogenous location to that of the Hprt locus
leads to a substantial change in the initial contact sites
of Xist accumulation. The new contact sites correlate
with the high-throughput chromosome conformation
capture (Hi-C) interactions of the new locus [15–17]
(Box 1). This strongly suggests that Xist exploits gen-
omic proximity and topology in order to spread in cis,
rather than depends on the presence of particular con-
sensus sequences, as occurs in Caenorhabditis elegans
[18] or in Drosophila [19]. Interestingly, the studies












Fig. 1 Models of the localization and spreading of Xist. a Three-dimensional spreading model of Xist localization. Xist might use close-proximity
sites for its initial spreading (left and middle panels) before accumulating over the whole chromosome. At the final stages of spreading, Xist shows
the highest enrichment at gene-rich regions (right panel). b Linear model of Xist spreading showing a classical representation of Xist decorating
G-light bands on metaphase chromosomes
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cell line as a reference for identifying regions that are
in close proximity, suggesting that the initial steps do
not depend on female-specific identifiers [16, 17].
The observation that early localization sites depend on
the location of Xist and appear to be exclusively position
dependent implies that, at least initially, the first contact
sites are not necessarily high-affinity ones. After this
first, proximity-driven, accumulation of Xist, Xist then
spreads to other target sites. This secondary spreading
might be a consequence of the initial contacts, chromo-
some reorganization or intrinsic site affinity. Given that
Xist spreading is likely to be a dynamic process, permis-
sive sites might be those at which Xist is more stably
retained [7, 13] (Fig. 1a). This model contrasts strongly
with the classic model that proposes linear spreading of
Xist along the X chromosome from the XIC [13, 14]
(Fig. 1b).
Through nuclear architecture and topology studies
of the X chromosome using the circular chromosome
conformation capture technique (4C), Splinter and col-
leagues showed that, upon differentiation of female
ESCs, the inactive X chromosome (Xi) loses the spe-
cific interactions between loci that are typical of the
active X chromosome (Xa) [20]. This could be due to
Xist binding sites differing in individual differentiated
cells [7]. Differential Xist binding in individual cells
might result in a loss of specific 4C signal at the level
of the overall cell population upon Xist-induced chro-
matin remodeling. Noticeably, CHART and Xist-
centered HiC profiles obtained at early time-points in
differentiation do show some degree of overlap. How-
ever, while Xist profiles obtained by CHART and RAP-
Seq are broad and diffuse [7, 8], the Xist-locus profile
generated using 4C and HiC is quite sharp, suggesting
only a few genomic locations are in close contact with
the XIC [20]. This apparent discrepancy could reflect
the preference of the latter technique for picking up
those genomic sites that interact most frequently or
are in closest proximity in most of the cells, while the
CHART and RAP-Seq profiles more typically represent
an ‘average’ signal of Xist contact sites within the over-
all population of cells [7, 8, 15, 16, 20]. Other differ-
ences might be reflections of different experimental
protocols — Splinter and colleagues [20], for instance,
used a differentiation protocol that enriches for a sin-
gle specific cell lineage [neuronal precursor cells
(NPCs)], whereas Simon et al. [8] and Engreitz et al.
[7] used withdrawal of leukemia inhibitory factor (LIF)
and differentiation by retinoic acid (RA), respectively.
The latter two conditions are known to lead to the dif-
ferentiation of a heterogeneous mixture of different
cell types (Box 1).
Interestingly, Splinter et al. [20] and Minajigi et al.
[21], provided evidence for the need for continuous
Xist expression in order to achieve proper folding of
the Xi. Indeed, a conditional deletion of Xist was
shown to be associated with a reshaping of the top-
ology of the Xi into an Xa-like conformation. Minajigi
et al. also suggest a role for the cohesin complex in
keeping Xa topologically associated domains (TADs) in
place. Such conformation changes might explain the
slightly higher rate of reactivation of X-linked genes in
Xist-deficient cells observed by the Jaenisch group in
the maintenance phase of XCI, which is otherwise
thought to be Xist independent [22]. As Xist seems to
interact directly with the lamin B receptor (LBR), a
protein mediating the interaction between chromatin
and lamin B [21, 23], this interaction could be a neces-
sary intermediate in keeping the Xi in the proximity of
the nuclear envelope, where heterochromatin is teth-
ered, thereby reinforcing or stabilizing the Xi conform-
ation and gene silencing [24] (Table 1).
An alternative method that has been applied to
studying Xist localization and Xi topology is fluores-
cence microscopy. Smeets et al. [25] and Cerase et al.
[26] have studied Xist localization by super-resolution
three dimensional structured illumination microscopy
(3D-SIM) [27], a technique that allows specimen im-
aging at sub-diffraction resolution (resolution limit
~100 nm; Box 1). Their findings challenge the idea of
a broad distribution of Xist along the Xi and suggest
that Xist, even when fully spread, might be in contact
with only a limited number of genomic sites at any
one time. Smeets and colleagues [25] have reported a
discrete number of Xist foci (approximately 100 per
cell) in fully differentiated and differentiating female
ESCs. As each focus might represent multiple Xist
molecules, the results are compatible with earlier esti-
mates of the number of Xist molecules, which are in
the range of 300 to 1000 per cell [28, 29]. The appar-
ent disagreement with the results of chromosome-
wide Xist profiling obtained by RAP and sequencing
by capture hybridization analysis of RNA targets
(CHART-seq) could reflect differences between the
analysis of pooled and single cells. For example, it is
clearly possible that Xist localizes to relatively few
genomic locations at any one time in a given cell and
yet appears as a broad domain when population-
based sequencing approaches are used. An alterna-
tive explanation could be that single RNA molecules
cannot be detected by RNA fluorescence in situ
hybridization [25].
Xist-mediated Polycomb recruitment and gene silencing
A much-debated aspect of XCI is the link between
Xist spreading and recruitment of Polycomb protein.
The most widely accepted model predicts a direct re-
cruitment of Polycomb by Xist RNA (Fig. 2a). This
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interaction has been reported to be mediated by the
structurally conserved Xist RepA domain, which
would interact directly with polycomb repressive complex
2 (PRC2) [30–33]. In agreement with this model, Engreitz
et al. [7] and Simon et al. [8] found linear correlations
between Xist and PRC2 localization and between Xist
and PRC2-mediated tri-methylation of lysine 27 of
histone H3 (H3K27me3). This agrees with previous
mapping studies of PRC2 on the X chromosome that
suggested a broad overall distribution of PRC2 and
H3K27me3 [34–36] following accumulation at discrete
sites (CpG islands) [36]. Most of the studies supporting
a direct recruitment model [30–33] have, however,
exploited in vitro biochemical approaches such as band-
Table 1 Factors involved in X chromosome inactivation
Factors involved in XCI Function in the context of XCI References
Proteins
PRC2 The polycomb repressive complex 2 (PRC2) is known to be recruited early on the inactive X (Xi) during
differentiation of embryonic stem cells (ESCs) and embryonic development and catalyzes methylation of
histone H3 at K27 on chromatin
[40, 80, 81]
PRC1 The activity of polycomb repressive complex 1 (PRC1) on chromatin reinforces gene silencing by
ubiquitylation of histone H2A at K119 and chromatin compaction. The order of recruitment of PRC2 and
PRC1 to the Xi is still a matter of debate
[82, 83]
Saf-A (HnrnpU) The Saf-A (HnrnpU) factor directly binds to Xist and mediates its interaction with chromatin through direct
interaction with SARS/MARS elements
[21, 23, 44,
56, 58]
SHARP (Spen) SHARP (Spen) directly binds to Xist and mediates the functional interaction between Xist and the NCoR
complex
[21, 23, 44]
CTCF The CCCTC-binding factor (CTCF) might work as a genomic insulator. In the context of X chromosome in-
activation (XCI), it might serve as a barrier to Xist-induced chromatin reorganization
[21, 67]
SATB1 The special AT-rich sequence-binding protein-1 (SATB1) cellular regulator of higher chromatin
organization has a role in the initiation of XCI. However, its precise role in XCI is not clear
[59, 84]
YY1 Yin-Yang 1 (YY1) is a bivalent protein with DNA-binding and RNA-binding motifs. It might have a role in
tethering Xist to chromatin (spreading in cis) as well as a role in the regulation of Xist
[44, 60, 85]
SmchD1 The protein structural maintenance of chromosome hinge domain 1 (SmchD1) has a role in maintaining
a correct pattern of DNA methylation on the Xi during the maintenance phase of XCI
[21, 86]
WTAP Wilms’ tumor-associated protein (WTAP) is a splicing factor and interactor with Xist. It is involved in regu-
lating RNA methylation. It might have a role in the post-transcriptional modification of Xist
[21, 23, 44]
LBR The lamin B receptor (LBR) was recently identified as an Xist-binding protein. It is known to localize with
the nuclear lamina and to interact with repressive complexes as well as with lamin B
[21, 23]
Rbm15 Rbm15 belongs to the SPEN family of transcriptional repressors and directly binds to Xist RNA [23]
hnRNPK Heterogeneous nuclear ribonucleoprotein K (hnRNPK) is an RNA-binding protein that interacts with Xist
and plays a role in the Xist-mediated recruitment of repressive chromatin marks
[21, 44]
Oct4, Sox2, Rex1, Nanog,
PRDM14, Klf4
Pluripotency factors and epigenetic regulators that have been shown to control XCI through the
regulation of Xist and Tsix
[2, 74, 87,
88]
Rnf12 The Rnf12 protein seems to regulate the expression of Xist through degradation of Rex1 [75]
Atrx The protein alpha thalassemia/mental retardation syndrome X-linked (Atrx) is involved in the recruitment
of PRC2 on the inactive X chromosome
[21, 89]
ncRNAs
Xist/Tsix Xist is the master regulator of XCI, and Tsix is its major antagonist. Regulation of the levels of Xist and Tsix
regulates the initiation of XCI
[2]
Jpx The Jpx ncRNA seems to act as an activator of Xist [2]
Ftx The Ftx ncRNA seems to be an Xist activator [2]
Genomic elements
LINEs The LINEs class of genomic repeats colocalize with inactive genes in the Xi territory and might have a
role in the establishment and maintenance of XCI
[43, 90, 91]
SARS/MARS Facultative scaffold/matrix attachment regions enriched in open chromatin and gene bodies where Xist
accumulates
[7, 66]
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shift assays and RNA immunoprecipitation (RNA-IP)
approaches (Box 1). Such techniques are notoriously
prone to false-positive results, reflecting non-specific
interactions between RNA and proteins.
An almost equally well-represented body of evidence
argues against the direct-interaction model. For in-
stance, some studies show that Xist upregulation clearly
precedes PRC2 recruitment in early mouse development
[37, 38], whereas others demonstrate that a RepA dele-
tion mutant version of Xist (ΔArep) is still fully able
to recruit PRC2 and H3K27me3 [37–40]. Still-other ob-
servations suggest that Xist expression in fully
differentiated cells is not sufficient to recruit PRC2. The
absence of PRC2 recruitment, upon Xist induction, is
not related to the expression level of this complex, as
the PRC2 complex is often expressed in such differenti-
ated cells [41].
More-recent observations made by Cerase and col-
leagues [26] using a 3D-SIM approach showed that the
bulk of Xist RNA and PRC2/PRC1 complexes are
clearly spatially separated. This finding argues strongly
against the direct-interaction model. The study used a
mouse male ESC carrying an inducible Xist transgene
(Xist-TG) inserted on chromosome 17 and capable of








Fig. 2 Direct and indirect models of recruitment of PRC2 by Xist RNA. a In the direct model, Xist localization brings PRC2 onto the chromatin by
direct recruitment (upper panel). The PRC2 complex then places the H3K27me3 mark on the chromatin (middle panel), and this is followed by
chromatin remodeler recruitment and chromatin compaction (lower panel). b In the indirect model, Xist interacts with gene-dense regions (upper
panel) and induces chromatin changes (middle panel; i.e. histone deacetylation induced by Hdac3, chromatin compaction, eviction of RNA poly-
merase II). These changes might, in turn, recruit PRC1 or PRC2 and remodeler complexes (lower panel). H3K27me2-3 dimethylated or trimethylated
histone 3 lysine 27, PRC1 polycomb repressive complex 1, PRC2 polycomb repressive complex 2
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Xist upregulation under undifferentiated conditions.
Whilst Xist spreading and localization could be influ-
enced by this autosomal context [25, 26, 42, 43] and by
the type of undifferentiated culture conditions used,
the main findings of this paper have been confirmed
using a fully differentiated female cell line [26].
The above study argues that the observed distance be-
tween Xist RNA and Polycomb proteins is likely to pre-
clude direct interaction between the PRC complex and
Xist (Fig. 2a). This interpretation is supported by results
from Smeets et al. [25], who showed that Xist localizes
to the inter-chromatin/perichromatin regions (IC/PR), a
non-DAPI-dense area that displays poor overlap with
H3K27me3 domains (correlating with DAPI-dense
chromatin compartments) (Box 1). Both lines of evi-
dence suggest an alternative model not only of how Xist
might recruit Polycomb proteins, but also more gener-
ally of the role of chromatin remodelers in X inactiva-
tion (Fig. 2b). According to the model, in agreement
with Engreitz et al. [7], Xist would initially interact with
gene-dense silent regions, possibly partially marked by
H3K27me3. It would then induce histone deacetylation,
chromatin compaction and the exclusion of Pol II and
the basal transcription machinery from nearby active re-
gions [21, 23, 44]. Silenced, compacted chromatin
would, in turn, recruit PRC2 and/or chromatin remode-
lers (indirect model; Fig. 2b) [23, 45, 46]. In accordance
with a two-step recruitment model of chromatin factors
by Xist, PRC2 initially would only accumulate at ap-
proximately 100 to 150 sites before spreading broadly
along the X chromosome [36].
Interestingly, Simon and colleagues showed that, when
Xist was stripped off the chromatin of female mouse em-
bryonic fibroblasts (MEFs) using complementary locked
nucleic acids (LNAs), the kinetics of re-attachment differed
from that of the de novo kinetics [8]. This suggests that Xist
could also function by priming the chromatin, possibly
making it a better substrate for Xist re-spreading after cell
division or for recruitment of repressive complexes (for ex-
ample, by histone deacetylation) [8, 26, 39]. Such an inter-
pretation is, however, in at least partial disagreement with a
study from Ng and colleagues, where Xist re-spreading
events were observed to occur with the same kinetics as
those seen in the initial round of Xist spreading [47].
Very recently, indirect recruitment of PRC2 by Xist has
been confirmed by two independent studies [23, 44],
which used biotinylated probes complementary to Xist to
pull down Xist-associated proteins for mass spectrometry
analysis. While McHugh and colleagues used UV cross-
linking conditions coupled with mass spectrometry under
denaturing conditions (RAP-MS) [23], Chu and colleagues
relied on formaldehyde crosslinking followed by mass
spectrometry in non-denaturing conditions (ChIRP-MS)
[44) (Box 1). The former technique allows recovery only
of direct RNA–protein interactors, whereas the latter also
allows recovery of proteins in the same complex or in
close proximity that are not interacting directly with Xist
[26]. The stringent conditions used by McHugh and col-
leagues allowed the specific isolation of ten bona fide Xist
direct interactors. By contrast, Chu and colleagues found
81 proteins that directly or indirectly associate with Xist.
Although Chu et al. reported a possible direct interaction
with the PRC1 complex [44], neither study listed members
of the PRC2 complex as Xist interactors. McHugh et al.
suggest that PRC2 recruitment is a consequence of his-
tone H3 deacetylation by Hdac3, part of the NCoR repres-
sive complex, and exclusion of Pol II [23, 48]. They also
suggest that the silencing mediator for the retinoic acid re-
ceptor and thyroid hormone receptor/nuclear receptor
co-repressor (SMRT/NCoR) complex is recruited to the
inactivating X via SMRT- and HDAC-associated repressor
complex/Msx2-interacting protein (SHARP/Spen), which
itself directly binds to Xist RNA [23, 44] (Fig. 2b). Both
knockdown of Hdac3 and of SHARP/Spen have similar
negative effects on PRC2 recruitment to the inactive X
and gene silencing. Chu et al. also suggest that heteroge-
neous nuclear ribonucleoprotein K (HnrnpK), an hetero-
geneous nuclear ribonucleoprotein similar to Saf-A, but
from which it differs in both binding sites and specificity,
might have a direct role in Polycomb recruitment [44].
The results from another very recent proteomics paper
[21] contrast with the findings of McHugh et al. and
Chu et al. The authors, while using an approach similar
to that used by McHugh et al. [22], describe 80 to 250
proteins interacting with Xist at any one time. Among
these they were able to identify RbAp46/RbAp48 pro-
teins as direct interactors with Xist. While these proteins
are part of the repressive complex PRC2, it should be
noted that they are also part of both the Nurd and Sin3
complexes [49].
Finally, roles have been proposed for Jarid2 and Pcl2,
two non-canonical subunits of PRC2 [50], in mediating
the recruitment of the PRC2 complex to the Xi [51,
52]. Knockdown and knockout experiments have
shown that PRC2 recruitment on the X is impaired in
the absence or reduction of these two PRC2 cofactors,
whereas Xist upregulation itself seems to be un-
affected. It should be noted that neither study [52, 53]
allowed for discrimination between direct versus indir-
ect PRC2 recruitment. Two interesting reviews have
addressed the issue of Xist-mediated PRC2 recruit-
ment in detail [54, 55].
Nuclear scaffolding and XCI
Important examples of other putative Xist-interacting
proteins that could be involved in Xist spreading and si-
lencing include nuclear scaffold proteins [25, 56–60]
(Table 1). The nuclear scaffold (also known as nuclear
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matrix) is a stable, proteinaceous structure that remains
after treating cell nuclei with high-salt buffers, deter-
gents and nucleases and might provide the framework
for chromatin organization. In particular, scaffold-
attachment or matrix-attachment regions (SARs or
MARs) could be mediating the interaction between
DNA and the matrix proteins in a highly regulated
fashion.
Fackelmayer and coworkers were the first to describe
the enrichment of Saf-A, a nuclear matrix protein, in the
Xi territory [56, 57]. Hasegawa and colleagues [58] sub-
sequently showed that Saf-A is necessary for Xist
localization in both neuroblasts and fully differentiated
MEFs. They also showed, using UV crosslinking condi-
tions and RNA-IP, that Xist and Saf-A might interact
directly [58]. It should be noted that the UV crosslinking
experiments performed by Hasegawa and colleagues are
less prone to artifacts than are band-shift assays and
non-crosslinked-formaldehyde IPs. This is because UV
crosslinking between RNA and proteins is only effective
over short distances [61] (Box 1). Nevertheless, nucleic-
acid–protein and protein–protein interactions — involv-
ing not only Xist and Saf-A, but also other components
— cannot be formally excluded. Smeet and colleagues
[25], using a GFP–Saf-A fusion protein, have confirmed
the enrichment of Saf-A on the Xi and have provided
additional evidence of a direct interaction between Xist
and the Saf-A protein. Using a 3D-SIM approach, they
evaluated the average distance between Saf-A and Xist
signals. Measured distances fall below the resolution
limits of the technique, implying at least some degree of
interaction. There is no reason to believe that the use of
formaldehyde-fixed cells calls into question the observed
interaction as Xist–matrix binding appears relatively
stable [62, 63]. The results of Smeet and colleagues sug-
gest that the Saf-A protein that is enriched on the Xi
could be post-translationally modified (Fig. 3a), an ob-
servation in possible agreement with the lack of recogni-
tion of Saf-A on the Xi by certain antibodies against Saf-
A [25]. The possibility of post-transcriptional modifica-
tions of the scaffold is of interest in the light of results
concerning Xist spreading in cis and fuels speculation
about the idea that Xist might interact with modified
matrix proteins on the presumptive inactive X and that
this would provide the mechanism for restricting Xist
RNA spreading to the chromosome from which it was
transcribed [64].
Chu et al. [44], McHugh et al. [23] and Minajigi et al.
[21] all identified Saf-A as an interactor with Xist, using
RAP-MS and ChIRP-MS, and confirmed the role of Saf-
A in Xist localization on the inactive X, substantiating
the previous findings of Hasegawa and colleagues [58].
Although the authors suggest a direct role for Saf-A in
Xist-mediated silencing, as Xist silencing is affected both
by a loss of Xist localization and by compaction, other
possibilities must be considered [23, 44].
It is tempting to push this model slightly further and















Fig. 3 Possible role of scaffold proteins in X chromosome inactivation. a The binding of Xist to modified scaffold proteins induces the
reorganization of the chromatin, as in (b), where Xist-mediated silencing is maintained by the nuclear scaffold. Genes to be silenced are dragged
towards the nuclear matrix, preventing engagement of transcription factors at regulatory sites. CCCTC-binding factor (CTCF) might serve as a bar-
rier to prevent Xist-induced chromatin reorganization. LINEs long interspersed nuclear elements
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scaffold proteins [63], mediating a chromosome-wide
reorganization of the chromosome [40, 65]. Interestingly,
facultative scaffold/matrix attachment regions (S/MARs)
are enriched in open chromatin regions and in gene bod-
ies, where Xist accumulates [7, 8, 66] (Box 1; Table 1). As
Simons et al. and Engreitz et al. have shown that Xist does
not accumulate on the gene body of escapee genes, which
are genes that avoid being silenced by Xist, and active
genes at early stages of XCI, we could further speculate
that Xist needs to access the gene bodies to achieve full
gene silencing. Under such a model, Xist would accumu-
late on S/MAR-enriched loci, interacting with post-
translationally modified Saf-A, triggering the relocation of
active genes close to repeat-dense regions (for example,
LINE-rich and lamin-bound regions) [40, 66], in agreement
with the model proposed by Chaumeil and colleagues [40]
(Fig. 3a, b). Moving active genes into the proximity of the
compacted/repeat-rich region of the Xi would prevent ac-
cess of the transcription factors to regulatory regions of
genes, resulting in silencing [35]. Escapee genes, through a
looping of the chromatin outside and away from the
repeat-dense region, would be protected from silencing
[40, 67]. CCCTC-binding factor (CTCF) is one factor that
has been reported to have a role in the organization of
chromosomal domains that efficiently escape XCI [67]
(Table 1). The Smeets et al. paper [25], however, challenges
the common view of a compacted central area of the Xi,
with active genes arranged at the periphery of the Xi [40,
63]. Instead, Smeets and colleagues suggest a honey-
combed structure, with the center of the Xi marked by
pockets of reduced compaction, which are permissive for
transcription [25]. Differences in the proposed structures
likely reflect differences in microscope resolution.
A very recent paper [68] also hints at a possible role
of the nuclear matrix in more-general chromatin
organization, suggesting that the interaction of non-
coding RNAs (ncRNAs) and the nuclear matrix might
be a more widespread phenomenon. The authors
showed an enrichment of C0T-1 RNA in euchromatic
regions that directly interact with the nuclear matrix.
Such interspersed repeat RNA, which mostly consists
of truncated 5′ L1 elements, could serve either to re-
cruit transcription factors or to act as a platform for
opening up the chromatin. We are tempted to specu-
late that Xist competes with C0t-1 RNA for scaffold at-
tachment sites in this context, triggering a release of
structural euchromatic RNA, a collapse of chromatin,
and triggering silencing [68] (Fig. 4a, b). Smeets and
colleagues offer a similar potential explanation for the
repressive function of Xist, linked to Xist coating of
the Xi, which would prompt a collapse of interchroma-













Fig. 4 A speculative model of Xist function. The central part of the diagram shows a nucleus, with the active (Xa) and the inactive (Xi)
chromosomal territories highlighted in green and yellow, respectively (gray indicates the chromosomal territories of other chromosomes).
Magnified views of the Xi (right) and the Xa (left) territories are shown. The following model is based on the observations of Smeets and
colleagues [25]. Coating with Xist RNA might cause a collapse of open chromatin channels, and this, in turn, might block the access of
transcription factors and RNA polymerase II (RNA Pol II) to gene-regulatory elements. Alternatively, Xist might compete with C0t-1 RNA, and
removal of this class of RNA could, in turn, lead to chromosome compaction [68]
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basal transcription factors to the chromatin. The ab-
sence of transcription would, in turn, trigger the re-
cruitment of repressive complexes (for example, PRC2/
PRC1 and DNA methyltransferases), inducing further
silencing (Fig. 4a, b). For more information about the
role of scaffolding in XCI, we refer the reader to two
recent reviews [69, 70].
Concluding remarks
Here, we have discussed several notable advances in
the field of Xist biology. The articles under review
represent important contributions to our understand-
ing of the mechanism(s) of Xist silencing, especially in
relation to four main areas for which there are
outstanding gaps in knowledge: (1) Xist spreading;
(2) Xi nuclear organization; (3) Polycomb/chromatin
remodeler recruitment and gene silencing; and (4)
Xist–matrix interactions.
The very recent papers of McHugh et al. [23], Chu et
al. [44] and Minajigi et al. [21] have critically shed light
on the previously elusive Xist-interacting proteins and
how Xist might both establish gene silencing by
Hdac3-mediated histone deacetylation and reinforce
gene silencing by tethering the inactive X chromosome
to the nuclear periphery through interaction with the
lamin B receptor (LBR) and topoisomerase remodeling
of the Xi.
However, many unresolved questions remain. For ex-
ample, currently available data do not allow determin-
ation of whether different Xist splicing variants have a
similar function and spreading pattern compared with
those of the full-length Xist RNA that is most often
exploited experimentally.
Several Xist splice variants have been described,
including two major forms [71–73]. More re-
cently a RepA variant of Xist RNA that seems to
mimic the full-length version has also been re-
ported [30]. Use of the male ESC Xist-inducible
system, which exploits a mature form of Xist,
and differentiating female ESC lines, in which
Xist transcription is subject to splicing, might
therefore not necessarily be completely inter-
changeable experimentally. A possible way to
make the systems more comparable would be to
include the relatively small introns of Xist in the
inducible constructs. This could be particularly
informative in the light of eventual Xist post-
transcriptional modifications, which are not ne-
cessarily confined to exons.
The regulation of Xist has been shown to be tightly
regulated by pluripotency factors [6, 74, 75], and the
pluripotent state of ESCs is known to be highly sensitive
to culture conditions. If, as seems likely, silencing initi-
ation and Xist spreading are sensitive to quantitative
variations in Xist RNA levels, ex vivo culture conditions
might also crucially impact inactivation parameters. For
example, ESCs grown in 2 inhibitor (2i) medium culture
conditions are known to be closer to the ‘ground zero’
state of pluripotency [76], to have a more homogeneous
composition [76] and to show different transcriptional
profiles compared with those of cells grown under con-
ventional LIF and serum conditions [77–79]. Both differ-
entiation and upregulation of XIC lncRNAs clearly occur
much faster using such 2i cultured cells, but whether the
underlying mechanisms differ or remain unchanged still
needs to be clarified. Only through standardization of ESC
culturing (for example, by consistent use of 2i culturing
conditions) and differentiation protocols (for example,
using NPC differentiation) will direct comparison of data
obtained in different experiments be possible.
Finally, given that the initial Xist spreading is likely to
vary between individual cells, validation at the single-cell
level, including single-cell RAP/CHART experiments,
will be key towards obtaining a more thorough
characterization and a better knowledge of Xist early dy-
namics. Such approaches would be expected to facilitate
the identification of causal correlations between possible
chromatin states and specific modifications of Xist bind-
ing sites.
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